Cargando…
Role of Metformin in Morbidity and Mortality Associated with Urinary Tract Infections in Patients with Type 2 Diabetes
We conducted this study to compare the morbidity and mortality associated with UTI and sepsis, between metformin users and nonusers in patients with diabetes. As such, 40,774 propensity score-matched metformin users and nonusers were identified from Taiwan’s National Health Insurance Research Databa...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144588/ https://www.ncbi.nlm.nih.gov/pubmed/35629125 http://dx.doi.org/10.3390/jpm12050702 |
_version_ | 1784716084793835520 |
---|---|
author | Yen, Fu-Shun Wei, James Cheng-Chung Shih, Ying-Hsiu Pan, Wei-Lin Hsu, Chih-Cheng Hwu, Chii-Min |
author_facet | Yen, Fu-Shun Wei, James Cheng-Chung Shih, Ying-Hsiu Pan, Wei-Lin Hsu, Chih-Cheng Hwu, Chii-Min |
author_sort | Yen, Fu-Shun |
collection | PubMed |
description | We conducted this study to compare the morbidity and mortality associated with UTI and sepsis, between metformin users and nonusers in patients with diabetes. As such, 40,774 propensity score-matched metformin users and nonusers were identified from Taiwan’s National Health Insurance Research Database, between 1 January 2000 and 31 December 2017. We adopted the Cox proportional hazards model with robust standard error estimates for comparing the risks of UTI, sepsis, and death due to UTI or sepsis, in patients with T2DM. Compared with the nonuse of metformin, the aHRs (95% CI) for metformin use in UTI, recurrent UTI, sepsis, and death due to UTI or sepsis were 1.06 (0.98, 1.15), 1.08 (0.97, 1.2), 1.01 (0.97, 1.06), and 0.58 (0.42, 0.8), respectively. The cumulative incidence of death due to UTI or sepsis was significantly lower in metformin users than in nonusers (p = 0.002). A longer cumulative duration of metformin use had a lower aHR in the risk of death due to UTI or sepsis than metformin nonuse. In patients with T2DM, metformin use showed no significant differences in the risks of UTI, recurrent UTI, or sepsis. However, it was associated with a lower risk of death due to UTI or sepsis than metformin nonuse. |
format | Online Article Text |
id | pubmed-9144588 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91445882022-05-29 Role of Metformin in Morbidity and Mortality Associated with Urinary Tract Infections in Patients with Type 2 Diabetes Yen, Fu-Shun Wei, James Cheng-Chung Shih, Ying-Hsiu Pan, Wei-Lin Hsu, Chih-Cheng Hwu, Chii-Min J Pers Med Article We conducted this study to compare the morbidity and mortality associated with UTI and sepsis, between metformin users and nonusers in patients with diabetes. As such, 40,774 propensity score-matched metformin users and nonusers were identified from Taiwan’s National Health Insurance Research Database, between 1 January 2000 and 31 December 2017. We adopted the Cox proportional hazards model with robust standard error estimates for comparing the risks of UTI, sepsis, and death due to UTI or sepsis, in patients with T2DM. Compared with the nonuse of metformin, the aHRs (95% CI) for metformin use in UTI, recurrent UTI, sepsis, and death due to UTI or sepsis were 1.06 (0.98, 1.15), 1.08 (0.97, 1.2), 1.01 (0.97, 1.06), and 0.58 (0.42, 0.8), respectively. The cumulative incidence of death due to UTI or sepsis was significantly lower in metformin users than in nonusers (p = 0.002). A longer cumulative duration of metformin use had a lower aHR in the risk of death due to UTI or sepsis than metformin nonuse. In patients with T2DM, metformin use showed no significant differences in the risks of UTI, recurrent UTI, or sepsis. However, it was associated with a lower risk of death due to UTI or sepsis than metformin nonuse. MDPI 2022-04-28 /pmc/articles/PMC9144588/ /pubmed/35629125 http://dx.doi.org/10.3390/jpm12050702 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Yen, Fu-Shun Wei, James Cheng-Chung Shih, Ying-Hsiu Pan, Wei-Lin Hsu, Chih-Cheng Hwu, Chii-Min Role of Metformin in Morbidity and Mortality Associated with Urinary Tract Infections in Patients with Type 2 Diabetes |
title | Role of Metformin in Morbidity and Mortality Associated with Urinary Tract Infections in Patients with Type 2 Diabetes |
title_full | Role of Metformin in Morbidity and Mortality Associated with Urinary Tract Infections in Patients with Type 2 Diabetes |
title_fullStr | Role of Metformin in Morbidity and Mortality Associated with Urinary Tract Infections in Patients with Type 2 Diabetes |
title_full_unstemmed | Role of Metformin in Morbidity and Mortality Associated with Urinary Tract Infections in Patients with Type 2 Diabetes |
title_short | Role of Metformin in Morbidity and Mortality Associated with Urinary Tract Infections in Patients with Type 2 Diabetes |
title_sort | role of metformin in morbidity and mortality associated with urinary tract infections in patients with type 2 diabetes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144588/ https://www.ncbi.nlm.nih.gov/pubmed/35629125 http://dx.doi.org/10.3390/jpm12050702 |
work_keys_str_mv | AT yenfushun roleofmetformininmorbidityandmortalityassociatedwithurinarytractinfectionsinpatientswithtype2diabetes AT weijameschengchung roleofmetformininmorbidityandmortalityassociatedwithurinarytractinfectionsinpatientswithtype2diabetes AT shihyinghsiu roleofmetformininmorbidityandmortalityassociatedwithurinarytractinfectionsinpatientswithtype2diabetes AT panweilin roleofmetformininmorbidityandmortalityassociatedwithurinarytractinfectionsinpatientswithtype2diabetes AT hsuchihcheng roleofmetformininmorbidityandmortalityassociatedwithurinarytractinfectionsinpatientswithtype2diabetes AT hwuchiimin roleofmetformininmorbidityandmortalityassociatedwithurinarytractinfectionsinpatientswithtype2diabetes |